<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=319805651697215&amp;ev=PageView&amp;noscript=1">

Cryoport Reports Record Results; Grows Revenue by 50% for the First Nine Months of Fiscal 2015

February 5, 2015

LAKE FOREST, CA – February 5, 2015 — Cryoport, Inc. (CYRX) today announced financial results for its fiscal third quarter and nine months ended December 31, 2014.

Read More


Tags: Frozen Shipping, Frozen, Life Sciences, CYRX 3Q FY15 Earnings Release, Cold Chain Logistics, Dry Shipper, Clinical Trials Logistics

Cryoport to Report Financial Results for Fiscal Third Quarter of 2015 and Provide Business Update on Thursday, February 5th

January 29, 2015

Lake Forest, CA, January 29, 2015 - Cryoport, Inc. (OTCBB:CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced it will release its financial results for the fiscal third quarter ended December 31, 2014 on Thursday, February 5th.  

Read More


Tags: Frozen Shipping, shipping solution, Frozen, sales force, Life Sciences, Cold Chain Logistics, Dry Shipper, cold shipping, Clinical Trials Logistics

Cryoport Expands Sales Force To Address Growing Life Sciences Industry Demand

January 26, 2015

Lake Forest, CA, January 26, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced the expansion and restructuring of its national sales force in the United States.

Read More


Tags: Frozen Shipping, shipping solution, Frozen, sales force, Life Sciences, Cold Chain Logistics, Dry Shipper, cold shipping, Clinical Trials Logistics